A4375
|
|
N-Acetyl-D-alanine
|
19436-52-3
|
131.1
|
|
|
A4625
|
|
N-Acetyl-L-alanine ~99%
|
97-69-8
|
131.1
|
|
|
A3133
|
|
Nα-Acetyl-L-arginine
|
155-84-0
|
216.2
|
|
|
A5625
|
|
N-Acetyl-DL-aspartic acid ≥95%
|
2545-40-6
|
175.1
|
|
|
A1509
|
|
Acetyl-DL-carnitine hydrochloride
|
2504-11-2
|
239.7
|
|
|
A9125
|
|
Nα-Acetyl-L-glutamine
|
2490-97-3
|
188.2
|
|
|
A0876
|
|
N-Acetyl-D-leucine
|
19764-30-8
|
173.2
|
|
|
A2010
|
|
Nα-Acetyl-L-lysine
|
1946-82-3
|
188.2
|
|
|
A4021
|
|
Nε-Acetyl-L-lysine
|
692-04-6
|
188.2
|
|
|
A1501
|
|
N-Acetyl-D-methionine ~99%
|
1509-92-8
|
191.3
|
|
|
A3626
|
|
Nα-Acetyl-L-ornithine
|
6205-08-9
|
174.2
|
|
|
01423
|
|
N-Acetyl-D-penicillamine for HPLC derivatization, ≥99.0% (T)
|
15537-71-0
|
191.3
|
|
|
59891
|
|
N-Acetyl-DL-β-phenylalanine ≥97.0% (HPLC)
|
40638-98-0
|
207.2
|
|
|
A4251
|
|
N-Acetyl-L-phenylalanine ethyl ester
|
2361-96-8
|
235.3
|
|
|
A7512
|
|
N-Acetyl-DL-phenylalanine β-naphthyl ester
|
20874-31-1
|
333.4
|
|
|
A0783
|
|
N-Acetyl-L-proline
|
68-95-1
|
157.2
|
|
|
A2638
|
|
N-Acetyl-DL-serine
|
97-14-3
|
147.1
|
|
|
A6376
|
|
N-Acetyl-L-tryptophan
|
1218-34-4
|
246.3
|
|
|
A6501
|
|
N-Acetyl-L-tryptophanamide
|
2382-79-8
|
245.3
|
|
|
T4446
|
|
N-Acetyl-L-tyrosine PharmaGrade, Ajinomoto, EP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
|
537-55-3
|
223.2
|
|
|
A6751
|
|
N-Acetyl-L-tyrosine ethyl ester monohydrate
|
36546-50-6
|
269.3
|
|
|
A7772
|
|
S-(5′-Adenosyl)-L-cysteine
|
35899-53-7
|
370.4
|
|
|
A4377
|
|
S-(5′-Adenosyl)-L-methionine iodide ≥80% (HPLC), ≥80% (spectrophotometric assay)
|
3493-13-8
|
526.4
|
|
|
05160
|
|
β-Alanine BioXtra, ≥99.0% (NT)
|
107-95-9
|
89.1
|
|
|
A7652
|
|
D-Alanine benzyl ester p-toluenesulfonate salt
|
41036-32-2
|
351.4
|
|
|
A3041
|
|
β-Alanine t-butyl ester hydrochloride
|
58620-93-2
|
181.7
|
|
|
A2005
|
|
DL-Alaninol hydrochloride ≥98%, crystalline
|
17016-92-1
|
111.6
|
|
|
A8378
|
|
DL-2-Allylglycine
|
7685-44-1
|
115.1
|
|
|
A8137
|
|
D-Allylglycine
|
54594-06-8
|
115.1
|
|
|
A0879
|
|
N-(4-Aminobenzoyl)-L-glutamic acid ≥98% (TLC)
|
4271-30-1
|
266.3
|
|
|
A0664
|
|
4-Aminobutylphosphonic acid ≥99%
|
35622-27-6
|
153.1
|
|
|
A1879
|
|
L-2-Aminobutyric acid ≥99% (titration)
|
1492-24-6
|
103.1
|
|
|
A2636
|
|
S-(2-Aminoethyl)-L-cysteine hydrochloride ≥98% (TLC)
|
4099-35-8
|
200.7
|
|
|
A5402
|
|
L-2-Amino-3-guanidinopropionic acid hydrochloride
|
1482-99-1
|
182.6
|
|
|
A1422
|
|
p-Aminohippuric acid ≥99%
|
61-78-9
|
194.2
|
|
|
A3759
|
|
p-Aminohippuric acid sodium salt
|
94-16-6
|
216.2
|
|
|
A9075
|
|
(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyric acid hydrochloride
|
128223-55-2
|
231.7
|
|
|
A7902
|
|
2-Amino-2-norbornanecarboxylic acid amino acid transport inhibitor
|
20448-79-7
|
155.2
|
|
|
A6553
|
|
DL-2-Amino-5-phosphonovaleric acid lithium salt ~95%
|
125229-62-1
|
203.1
|
|
|
A3913
|
|
L-Argininamide dihydrochloride
|
14975-30-5
|
246.1
|
|
|
A2883
|
|
L-Arginine ethyl ester dihydrochloride
|
36589-29-4
|
275.2
|
|
|
A1057
|
|
L-Aspartic acid β-(7-amido-4-methylcoumarin) fluorescent amino acid
|
133628-73-6
|
290.3
|
|
|
B2129
|
|
L-Aspartic acid β-benzyl ester
|
2177-63-1
|
223.2
|
|
|
A6508
|
|
L-Aspartic acid β-hydroxamate serine racemase inhibitor
|
1955-68-6
|
148.1
|
|
|
A8291
|
|
L-Aspartic acid β-methyl ester hydrochloride
|
16856-13-6
|
183.6
|
|
|
A1632
|
|
DL-7-Azatryptophan hydrate
|
7146-37-4
|
223.2
|
|
|
B4261
|
|
Biocytin ≥98% (TLC)
|
576-19-2
|
372.5
|
|
|
B1758
|
|
Biocytin hydrochloride ≥98% (TLC)
|
98930-70-2
|
372.5
|
|
|
C3205
|
|
Nα,Nα-Bis(carboxymethyl)-L-lysine trifluoroacetate salt ≥95% (TLC)
|
160369-83-5
|
376.3
|
|
|
T4631
|
|
N,N′-Bis(trifluoroacetyl)-L-lysine methyl ester ~98% (Any lower purity will be indicated on the label.)
|
1478-74-6
|
352.2
|
|
|
B1403
|
|
Boc-L-alaninal ≥98%
|
79069-50-4
|
173.2
|
|
|
B7144
|
|
α-Boc-Arg(Nω-Mesitylenesulfonyl)-OH cyclohexylammonium salt
|
68262-71-5
|
555.7
|
|
|
B7032
|
|
Boc-5-Cyclohexylstatine ≥98% (TLC)
|
98105-45-4
|
315.4
|
|
|
B2511
|
|
Boc-3,4-Dehydro-L-proline
|
51154-06-4
|
213.2
|
|
|
B9003
|
|
Boc-Glu-OBzl
|
30924-93-7
|
337.4
|
|
|
B2522
|
|
Boc-Glu-OtBu
|
24277-39-2
|
303.4
|
|
|
B4645
|
|
Boc-Homoser-OH
|
41088-86-2
|
219.2
|
|
|
B8254
|
|
Boc-Lys(Z)-OH
|
2389-45-9
|
380.4
|
|
|
09794
|
|
Boc-β-Phe-OH ≥96.0% (HPLC)
|
161024-80-2
|
265.3
|
|
|
B5890
|
|
S-tert-Butylmercapto-L-cysteine
|
30044-51-0
|
209.3
|
|
|
B2519
|
|
O-t-Butyl-L-tyrosine t-butyl ester hydrochloride
|
17083-23-7
|
329.9
|
|
|
09945
|
|
N-Butyryl-DL-homoserine lactone ≥96.0% (HPLC)
|
98426-48-3
|
171.2
|
|
|
C4375
|
|
N-Carbamyl-L-glutamic acid
|
1188-38-1
|
190.2
|
|
|
C4272
|
|
γ-Carboxy-D-glutamic acid
|
64153-47-5
|
191.1
|
|
|
C7757
|
|
S-Carboxymethyl-L-cysteine
|
638-23-3
|
179.2
|
|
|
C9500
|
|
(±)-Carnitine hydrochloride ≥98% (TLC)
|
461-05-2
|
197.7
|
|
|
BOCCCK
|
|
Cholecystokinin Fragment Kit, Boc Protected
|
|
|
|
|
C9650
|
|
β-Cyano-L-alanine ≥95%
|
6232-19-5
|
114.1
|
|
|
C3633
|
|
Cystathionine ≥90% (HPLC)
|
535-34-2
|
222.3
|
|
|
C2196
|
|
L-Cysteine S-sulfate ≥98% (TLC)
|
1637-71-4
|
201.2
|
|
|
D0125
|
|
Dansyl-L-alanine cyclohexylammonium salt fluorescent amino acid
|
53332-27-7
|
421.6
|
|
|
D0250
|
|
α-Dansyl-L-arginine hydrochloride
|
28217-22-3 (free base)
|
444
|
|
|
D0875
|
|
Dansylglycine fluorescent amino acid
|
1091-85-6
|
308.4
|
|
|
17248
|
|
N-Decanoyl-DL-homoserine lactone ≥97.0% (HPLC)
|
106983-36-2
|
255.4
|
|
|
D4893
|
|
3,4-Dehydro-L-proline
|
4043-88-3
|
113.1
|
|
|
D5018
|
|
3,4-Dehydro-L-proline methyl ester hydrochloride
|
51827-12-4
|
163.6
|
|
|
D3758
|
|
DL-2,4-Diaminobutyric acid dihydrochloride
|
65427-54-5
|
191.1
|
|
|
D0629
|
|
3,5-Diiodo-L-thyronine thyroid hormone analog
|
1041-01-6
|
525.1
|
|
|
D0754
|
|
3,5-Diiodo-L-tyrosine dihydrate crystalline
|
18835-59-1
|
469
|
|
|
D6382
|
|
N,N-Dimethylglycine hydrochloride
|
2491-06-7
|
139.6
|
|
|
17247
|
|
N-Dodecanoyl-DL-homoserine lactone ≥97.0% (HPLC)
|
18627-38-8
|
283.4
|
|
|
E6005
|
|
Ethionamide
|
536-33-4
|
166.2
|
|
|
E5139
|
|
DL-Ethionine ≥95% (TLC)
|
67-21-0
|
163.2
|
|
|
F5126
|
|
m-Fluoro-DL-phenylalanine
|
456-88-2
|
183.2
|
|
|
F5251
|
|
p-Fluoro-DL-phenylalanine
|
51-65-0
|
183.2
|
|
|
F7376
|
|
4-Fluoro-DL-tryptophan crystalline
|
25631-05-4
|
222.2
|
|
|
F0896
|
|
5-Fluoro-DL-tryptophan powder or crystals
|
154-08-5
|
222.2
|
|
|
F4505
|
|
m-Fluoro-DL-tyrosine
|
403-90-7
|
199.2
|
|
|
95727
|
|
Fmoc-D-Homoser(Trt)-OH ≥98.0% (HPLC)
|
257886-01-4
|
583.7
|
|
|
F0148
|
|
Fmoc-Ser(tBu)-ODhbt
|
109434-27-7
|
528.6
|
|
|
F3377
|
|
N-Formyl-L-methionine ≥90% (TLC)
|
4289-98-9
|
177.2
|
|
|
G1763
|
|
β-Glutamic acid
|
1948-48-7
|
147.1
|
|
|
G7501
|
|
L-Glutamic acid di-tert-butyl ester hydrochloride
|
32677-01-3
|
295.8
|
|
|
G2253
|
|
L-Glutamic acid γ-monohydroxamate
|
1955-67-5
|
162.1
|
|
|
G9375
|
|
L-Glutamine t-butyl ester hydrochloride crystalline
|
39741-62-3
|
238.7
|
|
|
G3894
|
|
γ-D-Glutamylaminomethylsulfonic acid
|
90237-02-8
|
240.2
|
|
|
50070
|
|
Glycinamide hydrochloride ≥99.0% (AT)
|
1668-10-6
|
110.5
|
|
|
G7251
|
|
Glycine anhydride cyclic dipeptide
|
106-57-0
|
114.1
|
|
|
G3267
|
|
Glycine benzyl ester hydrochloride
|
2462-31-9
|
201.7
|
|
|
G5761
|
|
Glycine β-naphthylamide hydrochloride
|
1208-12-4
|
236.7
|
|
|
G6503
|
|
4-Guanidinobutyric acid ≥98%
|
463-00-3
|
145.2
|
|
|
G6878
|
|
3-Guanidinopropionic acid
|
353-09-3
|
131.1
|
|
|
10939
|
|
N-Heptanoyl-DL-homoserine lactone ≥97.0% (HPLC)
|
106983-26-0
|
213.3
|
|
|
09926
|
|
N-Hexanoyl-DL-homoserine lactone ≥97.0% (HPLC)
|
106983-28-2
|
199.3
|
|
|
80666
|
|
Hexarelin ≥90% (HPLC)
|
140703-51-1
|
887
|
|
|
H6759
|
|
L-Histidine β-naphthylamide powder
|
7424-15-9
|
280.3
|
|
|
H6503
|
|
L-Homocysteine thiolactone hydrochloride ≥98% (TLC)
|
31828-68-9
|
153.6
|
|
|
H5134
|
|
D-Homocystine
|
6027-15-2
|
268.4
|
|
|
H6010
|
|
L-Homocystine ≥98% (HPLC)
|
626-72-2
|
268.4
|
|
|
H0501
|
|
DL-Homocystine
|
870-93-9
|
268.4
|
|
|
03768
|
|
′L-β-Homoproline′ hydrochloride ≥98.0% (TLC)
|
53912-85-9
|
165.6
|
|
|
H4021
|
|
D-Homoserine
|
6027-21-0
|
119.1
|
|
|
H7890
|
|
L-Homoserine lactone hydrochloride
|
2185-02-6
|
137.6
|
|
|
H0377
|
|
DL-5-Hydroxylysine hydrochloride
|
13204-98-3
|
198.7
|
|
|
H4002
|
|
DL-3-Hydroxynorvaline ≥98% (TLC)
|
2280-42-4
|
133.2
|
|
|
H5877
|
|
cis-4-Hydroxy-D-proline
|
2584-71-6
|
131.1
|
|
|
H1637
|
|
cis-4-Hydroxy-L-proline collagen synthesis inhibitor
|
618-27-9
|
131.1
|
|
|
H7259
|
|
trans-4-Hydroxy-L-proline β-naphthylamide
|
3326-64-5
|
256.3
|
|
|